Tuoxin Pharmaceutical Reports Current Focus on Food-Grade CoQ10 Sales, Actively Expanding into Pharmaceutical Market

Deep News04-10

Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) stated on April 10 via an investor interaction platform that the company's current Coenzyme Q10 raw material products are primarily sold as food-grade. The company is actively developing its expansion into the pharmaceutical-grade market. The statement was made in response to an investor inquiry regarding progress on sample submissions, customer validation, order negotiations, potential framework agreements, the timeline for scaled sales, and the price difference between pharmaceutical-grade and food-grade products following the company's acquisition of pharmaceutical-grade Coenzyme Q10 production qualifications in February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171065897?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-10 12:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171065897","market":"nz","top_or_hot":-1,"title":"Tuoxin Pharmaceutical Reports Current Focus on Food-Grade CoQ10 Sales, Actively Expanding into Pharmaceutical Market","media":"Deep News","content":"<p>Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) stated on April 10 via an investor interaction platform that the company's current Coenzyme Q10 raw material products are primarily sold as food-grade. The company is actively developing its expansion into the pharmaceutical-grade market. The statement was made in response to an investor inquiry regarding progress on sample submissions, customer validation, order negotiations, potential framework agreements, the timeline for scaled sales, and the price difference between pharmaceutical-grade and food-grade products following the company's acquisition of pharmaceutical-grade Coenzyme Q10 production qualifications in February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tuoxin Pharmaceutical Reports Current Focus on Food-Grade CoQ10 Sales, Actively Expanding into Pharmaceutical Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTuoxin Pharmaceutical Reports Current Focus on Food-Grade CoQ10 Sales, Actively Expanding into Pharmaceutical Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-04-10 12:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) stated on April 10 via an investor interaction platform that the company's current Coenzyme Q10 raw material products are primarily sold as food-grade. The company is actively developing its expansion into the pharmaceutical-grade market. The statement was made in response to an investor inquiry regarding progress on sample submissions, customer validation, order negotiations, potential framework agreements, the timeline for scaled sales, and the price difference between pharmaceutical-grade and food-grade products following the company's acquisition of pharmaceutical-grade Coenzyme Q10 production qualifications in February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1171065897","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171065897","pubTimestamp":1775795428,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) stated on April 10 via an investor interaction platform that the company's current Coenzyme Q10 raw material products are primarily sold as...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","301089":"拓新药业","BK0239":"医药制造","BK1515":"抗疫概念","BK1161":"生物科技","BK1574":"生物医药B类股","09939":"开拓药业-B"},"translate_title":"拓新药业报告目前专注食品级CoQ10销售，积极拓展医药市场","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"301089":1,"09939":1},"content_text":"Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) stated on April 10 via an investor interaction platform that the company's current Coenzyme Q10 raw material products are primarily sold as food-grade. The company is actively developing its expansion into the pharmaceutical-grade market. The statement was made in response to an investor inquiry regarding progress on sample submissions, customer validation, order negotiations, potential framework agreements, the timeline for scaled sales, and the price difference between pharmaceutical-grade and food-grade products following the company's acquisition of pharmaceutical-grade Coenzyme Q10 production qualifications in February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171065897","isCrawlerRequest":true}